04.10.2018
- Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...
04.08.2017
- Swiss fine chemicals and biologics producer Lonza has acquired Micro-Macinazione, a contract manufacturer providing micronization of active ingredients for the pharmaceutical and...
04.02.2016
- Swiss fine and specialty chemical producer Lonza is building up its capabilities for drug development and manufacturing services to meet customers’ clinical outsourcing needs. The...
